NYSE · INDUSTRIAL ORGANIC CHEMICALS · LARGE CAP
Newmarket Corporation NEU
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY7 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$2.7B
▼ 2.2% vs FY2024
Dividend streak
7 yrs
Raised every year since 2019
EPS · FY25
$44.44
Dividend / sh · FY25
$11.25
Payout · FY25
25%
ROE · FY25
25.8%
Net margin · FY25
15.4%
Dividend coverage
4.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.7B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
15 cents of every revenue dollar became profit this year.
Per share
USD 44.44
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 4.0 times — the rest stayed in the company.
Profitability
25.8%
Return on equity, FY2025
ROE
Operating margin20.0%
Net margin15.4%
Return on assets12.6%
Each USD of equity produced 26 cents of profit this year.
Returned to shareholders
USD 183.1M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 105.9M
Net buybacksUSD 77.2M
Share of profit43.7%
Consecutive raises7 years
USD 105.9M in dividends and USD 77.2M in buybacks — 44% of the year's profit went back to shareholders.
Growth
+6.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−0.5%
+6.3%
+2.4%
+2.8%
Net income
+14.4%
+9.1%
+5.8%
+5.9%
EPS, diluted
+17.0%
+12.5%
+8.6%
+9.1%
Dividend / share
+10.2%
+8.2%
+6.8%
+14.1%
Returned to shareholders
−14.4%
−0.2%
−3.7%
+1.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years−14.0%
Change, 10 years−21.4%
The share count shrank 14% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.5B
total assets, end of FY2025
Total assetsUSD 3.5B
EquityUSD 1.8B
CashUSD 77.6M
Gross debtUSD 883.4M
Net debtUSD 805.8M
Current ratio2.53×
Net debt stands at 45% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
2.7
2.8
2.7
2.8
2.4
2.0
2.2
2.3
2.2
2.0
2.1
2.3
2.3
2.2
2.1
1.8
1.5
1.6
Operating income $B
0.5
0.6
0.5
0.4
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.1
EBITDA $B
0.7
0.7
0.6
0.4
0.3
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.1
Income tax $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
Net income $B
0.4
0.5
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.1
EPS, diluted $
44.44
48.22
40.44
27.77
17.71
24.64
22.73
20.34
16.08
20.54
19.45
18.38
19.90
17.85
15.09
12.09
10.65
4.75
Dividend / sh $
11.25
10.00
8.85
8.40
8.00
7.60
7.30
7.00
7.00
6.40
5.80
4.70
3.80
·
2.39
1.56
1.07
0.80
Payout %
25
21
22
30
45
31
32
34
44
31
30
25
19
157
16
13
10
21
ROE %
25.8
36.4
42.3
36.7
25.1
37.5
43.4
43.0
35.1
55.9
59.0
47.0
54.3
50.3
39.7
37.3
43.3
25.2
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed